top of page

BMO's Evan Seigerman joins Analyst Thursdays from London

Evan Seigerman discusses weight loss news from #AHA23, what's going on with Structure, Verve's polarizing result, Neurocrine, Vertex, Pfizer, and an #ASH23 preview.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page